About the Program
The objective of this one-year fellowship is to provide a concentrated experience in diagnostic cytopathology including the interpretation of both aspiration and exfoliative cytologies and the performance of superficial needle aspirations. There are six full-time, ACGME accredited fellowship positions available.
The fellow participates in a number of teaching cytology conferences can attend a variety of surgical pathology conferences, and must ready a research project for publication under staff supervision.
Supplementation of the gynecologic cytology portion of the program is achieved through a two-week rotation with the Methodist Hospital and a mandatory 400-slide gynecologic cytology study set review.
Immediate assessment of specimen adequacy is made for all aspirations (superficial and deep CT, ultrasound and endoscopic ultrasound). Interaction with surgical pathology and the submission/ interpretation of ancillary tests, such as flow cytometry, immunohistochemistry, molecular pathology and image analysis are part of the evaluation of many cytology specimens.
Approximately 31,000 cases are processed annually with 75% representing non-gynecologic specimens, including 11,500 needle aspirations. Selected specimens (primarily urine) are evaluated for DNA content (image analysis) or chromosomal abnormalities (FISH) within the cytology laboratory.
Candidates must complete a four-year AP/CP or three-year AP residency and must hold or be eligible to hold a Texas medical license.
Please check complete GME Eligibility Requirements prior to applying.
To be considered for an interview, your file must be complete before July 15 (24 months prior to the start of the training year), which begins July 1.
Commensurate with the candidate’s level of training.
Nancy P. Caraway, M.D.
Program Director, Cytopathology Fellowship
Department of Pathology and Laboratory Medicine
1515 Holcombe Blvd., Unit 53
Houston, TX 77030
For inquiries, please contact:
Verification of training
Requests for verification should be sent to email@example.com.
MD Anderson Cancer Center is committed to encouraging good health and staying true to our mission to end cancer. If you are applying for a GME fellowship or residency program starting on or after July 1, 2016, please be advised that MD Anderson will have instituted a tobacco-free hiring process as part of its efforts to achieve these goals. If you are offered an appointment, you will be subject to a Pre-Employment Drug Screen for tobacco compounds in compliance with applicable state laws. If you do not pass the urine drug screening which includes testing for tobacco compounds, you CANNOT be appointed at MD Anderson. Should you fail to meet this contingency, MD Anderson will withdraw your offer of appointment for the academic year. You may reapply for the following academic year, but there are no guarantees that you will be offered a position as many of our programs are already filled for several years out.